Entero-Insular Axis

Immunoassay of endogenous plasma insulin in man

Yalow, R. S., & Berson, S. A. (1960) · Journal of Clinical Investigation · doi:10.1172/jci104130 · Cited by 3,041 · see citing works

Plasma Insulin Responses to Oral and Intravenous Glucose: Studies in Normal and Diabetic Subjects*

Perley, M. J., & Kipnis, D. M. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105685 · Cited by 917 · see citing works

Plasma Insulin Response to Oral and Intravenous Glucose Administration1

ELRICK, H., STIMMLER, L., HLAD, C. J., & ARAI, Y. (1964) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-24-10-1076 · Cited by 857 · see citing works

New Interpretation of Oral Glucose Tolerance

Mcintyre, N., Holdsworth, C. D., & Turner, D. S. (1964) · The Lancet · doi:10.1016/s0140-6736(64)90011-x · Cited by 738 · see citing works

The Effects of Secretin, Pancreozymin, and Gastrin on Insulin and Glucagon Secretion in Anesthetized Dogs *

Unger, R. H., Ketterer, H., Dupré, J., & Eisentraut, A. M. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105565 · Cited by 337 · see citing works

Characterization of the responses of circulating glucagon-like immunoreactivity to intraduodenal and intravenous administration of glucose

Unger, R. H., Ohneda, A., Valverde, I., Eisentraut, A. M., & Exton, J. H. (1968) · Journal of Clinical Investigation · doi:10.1172/jci105714 · Cited by 296 · see citing works

GLUCAGON ANTIBODIES AND AN IMMUNOASSAY FOR GLUCAGON*

Unger, R. H., Eisentraut, A. M., McCall, M. S., & Madison, L. L. (1961) · Journal of Clinical Investigation · doi:10.1172/jci104357 · Cited by 285 · see citing works

On the treatment of <i>Diabetus mellitus</i> by acid extract of Duodenal Mucous Membrane

Moore, B., Edie, E. S., & Abram, J. H. (1906) · Biochemical Journal · doi:10.1042/bj0010028 · Cited by 279 · see citing works

Physiological Determination of Release of Secretin and Pancreozymin From Intestine of Dogs With Transplanted Pancreas

Wang, C. C., & Grossman, M. I. (1951) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1951.164.2.527 · Cited by 230 · see citing works

Characterization of response of circulating glucagon to intraduodenal and intravenous administration of amino acids

Ohneda, A., Parada, E., Eisentraut, A. M., & Unger, R. H. (1968) · Journal of Clinical Investigation · doi:10.1172/jci105916 · Cited by 200 · see citing works

STIMULATION OF GLUCAGON SECRETION BY ORAL GLUCOSE

Samols, E., Tyler, J., Marri, G., & Marks, V. (1965) · The Lancet · doi:10.1016/s0140-6736(65)92278-6 · Cited by 145 · see citing works

EFFECTS OF SECRETIN ON INSULIN AND GLUCAGON IN PORTAL AND PERIPHERAL BLOOD IN MAN

Dupré, J., Rojas, L., White, J. J., Unger, R. H., & Beck, J. C. (1966) · The Lancet · doi:10.1016/s0140-6736(66)91750-8 · Cited by 114 · see citing works

AN INTESTINAL HORMONE AFFECTING GLUCOSE DISPOSAL IN MAN

Dupré, J. (1964) · The Lancet · doi:10.1016/s0140-6736(64)92481-x · Cited by 110 · see citing works

Radioimmunoassayable glucagon levels in man: effects of starvation, hypoglycemia, and glucose administration.

Lawrence, A. M. (1966) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.55.2.316 · Cited by 91 · see citing works

Demonstration and Characterization of a Second Fraction of Glucagon-Like Immunoreactivity in Jejunal Extracts

Valverde, I., Rigopoulou, D., Exton, J. H., Ohneda, A., Eisentraut, A. M., & Unger, R. H. (1968) · The American Journal of the Medical Sciences · doi:10.1097/00000441-196806000-00007 · Cited by 89 · see citing works

Plasma Insulin Activity after Glucose: An Index of Insulogenic Reserve in Normal and Diabetic Man

Seltzer, H. S., & Smith, W. L. (1959) · Diabetes · doi:10.2337/diab.8.6.417 · Cited by 87 · see citing works

Stimulation of Insulin Secretion by Pancreozymin

Meade, R. C., Kneubuhler, H. A., SCHULTE, W. J., & Barboriak, J. J. (1967) · Diabetes · doi:10.2337/diab.16.3.141 · Cited by 77 · see citing works

EFFECT OF SECRETIN ON INSULIN SECRETION

Unger, R. H., Ketterer, H., Eisentraut, A. M., & Dupré, J. (1966) · The Lancet · doi:10.1016/s0140-6736(66)91749-1 · Cited by 75 · see citing works

IS A DUODENAL HORMONE INVOLVED IN CARBOHYDRATE METABOLISM?

Loew, E. R., Gray, J. S., & Ivy, A. C. (1940) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1940.129.3.659 · Cited by 48 · see citing works

Augmentation De L’Insuline Tissulaire Et De L’Insuline Circulante Apres Ingestion De Glucose

Bastenie, P. A., Conard, V., Franckson, J. R. M., Bellens, R., & Christophe, J. (1958) · Acta Clinica Belgica · doi:10.1080/17843286.1958.11717487 · Cited by 2 · see citing works

Reduced incretin effect in Type 2 (non-insulin dependent) diabetes

Nauck, M., Stöckmann, F., Ebert, R., & Creutzfeldt, W. (1986) · Diabetologia · doi:10.1007/bf02427280 · Cited by 1,307 · see citing works

Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV.

Kieffer, T. J., McIntosh, C. H., & Pederson, R. A. (1995) · Endocrinology · doi:10.1210/endo.136.8.7628397 · Cited by 1,124 · see citing works

The Glucagon-Like Peptides

Kieffer, T. J., & Habener, J. F. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.6.0385 · Cited by 1,056 · see citing works

Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1.

Thorens, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.18.8641 · Cited by 906 · see citing works

Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas.

Mojsov, S., Weir, G. C., & Habener, J. F. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112855 · Cited by 882 · see citing works

Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses

NAUCK, M. A., HOMBERGER, E., SIEGEL, E. G., ALLEN, R. C., EATON, R. P., EBERT, R., & CREUTZFELDT, W. (1986) · The Journal of Clinical Endocrinology &amp; Metabolism · doi:10.1210/jcem-63-2-492 · Cited by 874 · see citing works

The incretin concept today

Creutzfeldt, W. (1979) · Diabetologia · doi:10.1007/bf01225454 · Cited by 731 · see citing works

Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans

Holst, J. J., & Gromada, J. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00545.2003 · Cited by 611 · see citing works

Coffee acutely modifies gastrointestinal hormone secretion and glucose tolerance in humans: glycemic effects of chlorogenic acid and caffeine

Johnston, K. L., Clifford, M. N., & Morgan, L. M. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/78.4.728 · Cited by 590 · see citing works

Ghrelin, CCK, GLP-1, and PYY(3–36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB

Steinert, R. E., Feinle-Bisset, C., Asarian, L., Horowitz, M., Beglinger, C., & Geary, N. (2017) · Physiological Reviews · doi:10.1152/physrev.00031.2014 · Cited by 578 · see citing works

Cloning and Functional Expression of the Human Islet GLP-1 Receptor: Demonstration That Exendin-4 Is an Agonist and Exendin-(9–39) an Antagonist of the Receptor

Thorens, B., Porret, A., Bühler, L. H., Deng, S., Morel, P., & Widmann, C. (1993) · Diabetes · doi:10.2337/diab.42.11.1678 · Cited by 552 · see citing works

Cell and Molecular Biology of the Incretin Hormones Glucagon-Like Peptide-I and Glucose-Dependent Insulin Releasing Polypeptide

Fehmann, H. C., Göke, R., & Göke, B. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-3-390 · Cited by 527 · see citing works

International Union of Pharmacology. XXXV. The Glucagon Receptor Family

Mayo, K. E., Miller, L. J., BATAILLE, D., Dalle, S., Göke, B., Thorens, B., & Drucker, D. J. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.1.6 · Cited by 507 · see citing works

The incretin effect in healthy individuals and those with type 2 diabetes: Physiology, pathophysiology, and response to therapeutic interventions

Nauck, M. A., & Meier, J. J. (2016) · The Lancet Diabetes &amp; Endocrinology · doi:10.1016/s2213-8587(15)00482-9 · Cited by 503 · see citing works

Glucose intolerance caused by a defect in the entero-insular axis: A study in gastric inhibitory polypeptide receptor knockout mice

Miyawaki, K., Yamada, Y., Yano, H., Niwa, H., Ban, N., Ihara, Y., Kubota, A., Fujimoto, S., Kajikawa, M., Kuroe, A., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.14843 · Cited by 454 · see citing works

Tissue-specific expression of the human receptor for glucagon-like peptide-I: Brain, heart and pancreatic forms have the same deduced amino acid sequences

Wei, Y., & Mojsov, S. (1995) · FEBS Letters · doi:10.1016/0014-5793(94)01430-9 · Cited by 450 · see citing works

Insulinotropic hormone glucagon-like peptide-I(7-37) stimulation of proinsulin gene expression and proinsulin biosynthesis in insulinoma beta TC-1 cells

Fehmann, H. C., & Habener, J. F. (1992) · Endocrinology · doi:10.1210/endo.130.1.1309325 · Cited by 337 · see citing works

Identification and Actions of Gastric Inhibitory Polypeptide

Brown, J. C., Dryburgh, J. R., ROSS, S. A., & DUPRÉ, J. (1975) · Elsevier eBooks · doi:10.1016/b978-0-12-571131-9.50017-7 · Cited by 333 · see citing works

Double Incretin Receptor Knockout (DIRKO) Mice Reveal an Essential Role for the Enteroinsular Axis in Transducing the Glucoregulatory Actions of DPP-IV Inhibitors

Hansotia, T., Baggio, L. L., Delmeire, D., Hinke, S. A., Yamada, Y., Tsukiyama, K., Seino, Y., Holst, J. J., Schuit, F., & Drucker, D. J. (2004) · Diabetes · doi:10.2337/diabetes.53.5.1326 · Cited by 309 · see citing works

The insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7–37) in normal and diabetic subjects

Elahi, D., McAloon-Dyke, M., Fukagawa, N. K., Meneilly, G. S., Sclater, A. L., Minaker, K. L., Habener, J. F., & Andersen, D. K. (1994) · Regulatory Peptides · doi:10.1016/0167-0115(94)90136-8 · Cited by 308 · see citing works

Extrapancreatic incretin receptors modulate glucose homeostasis, body weight, and energy expenditure

Hansotia, T., Maida, A., Flock, G., Yamada, Y., Tsukiyama, K., Seino, Y., & Drucker, D. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci25483 · Cited by 290 · see citing works

Analysis of upstream glucokinase promoter activity in transgenic mice and identification of glucokinase in rare neuroendocrine cells in the brain and gut.

Jetton, T. L., Liang, Y. T., Pettepher, C. C., Zimmerman, E. C., Cox, F., Horvath, K., Matschinsky, F. M., & Magnuson, M. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41910-7 · Cited by 279 · see citing works

New developments in the incretin concept

Creutzfeldt, W., & Ebert, R. (1985) · Diabetologia · doi:10.1007/bf00281990 · Cited by 277 · see citing works

Glucose metabolism and hyperglycemia

Giugliano, D., Ceriello, A., & Esposito, K. (2008) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.1.217s · Cited by 278 · see citing works

The importance of first-phase insulin secretion: implications for the therapy of type 2 diabetes mellitus

Prato, S. D., & Tiengo, A. (2001) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.198 · Cited by 237 · see citing works

The Effect of Liraglutide, a Long-Acting Glucagon-Like Peptide 1 Derivative, on Glycemic Control, Body Composition, and 24-h Energy Expenditure in Patients With Type 2 Diabetes

Harder, H., Nielsen, L., Thi, T. D. T., & Astrup, A. V. (2004) · Diabetes Care · doi:10.2337/diacare.27.8.1915 · Cited by 232 · see citing works

Long-Term Treatment With the Dipeptidyl Peptidase IV Inhibitor P32/98 Causes Sustained Improvements in Glucose Tolerance, Insulin Sensitivity, Hyperinsulinemia, and β-Cell Glucose Responsiveness in VDF (fa/fa) Zucker Rats

Pospisilik, J. A., Stafford, S. G., Demuth, H.-U., Brownsey, R. W., Parkhouse, W. S., Finegood, D. T., McIntosh, C. H. S., & Pederson, R. A. (2002) · Diabetes · doi:10.2337/diabetes.51.4.943 · Cited by 232 · see citing works

Initial splanchnic extraction of ingested glucose in normal man

Radziuk, J., McDonald, T. J., Rubenstein, D., & Dupre, J. (1978) · Metabolism · doi:10.1016/0026-0495(78)90003-3 · Cited by 207 · see citing works

Vagal hepatopancreatic reflex effect evoked by intraportal appearance of tGLP-1

Nakabayashi, H., NISHIZAWA, M., Nakagawa, A., Takeda, R., & Niijima, A. (1996) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1996.271.5.e808 · Cited by 203 · see citing works

Narrative Review: Effect of Bariatric Surgery on Type 2 Diabetes Mellitus

Vetter, M. L., Cardillo, S., Rickels, M. R., & Iqbal, N. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-2-200901200-00007 · Cited by 192 · see citing works

Glucagon-like peptide-1 is a physiological incretin in rat.

Wang, Z., Wang, R. M., Owji, A. A., Smith, D. M., Ghatei, M. A., & Bloom, S. R. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117671 · Cited by 190 · see citing works

Changes in Insulin Resistance Following Bariatric Surgery: Role of Caloric Restriction and Weight Loss

Gumbs, A. A., Modlin, I. M., & Ballantyne, G. H. (2005) · Obesity Surgery · doi:10.1381/0960892053723367 · Cited by 188 · see citing works

Physiology of incretins (GIP and GLP-1) and abnormalities in type 2 diabetes

Gautier, J. F., Choukem, S. P., & Girard, J. R. (2008) · Diabetes & Metabolism · doi:10.1016/s1262-3636(08)73397-4 · Cited by 181 · see citing works

GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout mice

Hansotia, T., & Drucker, D. J. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2004.07.019 · Cited by 182 · see citing works

Gut hormones and diabetes mellitus

Creutzfeldt, W., & Nauck, M. (1992) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610080206 · Cited by 176 · see citing works

First-phase insulin secretion: does it exist in real life? Considerations on shape and function

Caumo, A., & Luzi, L. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00139.2003 · Cited by 174 · see citing works

Receptors and effects of gut hormones in three osteoblastic cell lines

Pacheco-Pantoja, E. L., Ranganath, L. R., Gallagher, J. A., Wilson, P. J., & Fraser, W. D. (2011) · BMC Physiology · doi:10.1186/1472-6793-11-12 · Cited by 173 · see citing works

Chapter 15 Glucose‐Dependent Insulinotropic Polypeptide (Gastric Inhibitory Polypeptide; GIP)

McIntosh, C. H. S., Widenmaier, S. B., & Kim, S. (2009) · Vitamins and hormones · doi:10.1016/s0083-6729(08)00615-8 · Cited by 172 · see citing works

The Effect of Gastrin on Basal- and Glucose-Stimulated Insulin Secretion in Man

Rehfeld, J. F., & STADIL, F. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107315 · Cited by 165 · see citing works

Biological actions of the incretins GIP and GLP-1 and therapeutic perspectives in patients with type 2 diabetes

Gautier, J. F., Fetita, S., Sobngwi, E., & Salaun-Martin, C. (2005) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70190-8 · Cited by 163 · see citing works

Physiologic relevance of heterogeneity in the pancreatic beta-cell population

PIPELEERS, D. G., Kiekens, R., Ling, Z., Wilikens, A., & Schuit, F. C. (1994) · Diabetologia · doi:10.1007/bf00400827 · Cited by 152 · see citing works

Postprandial stimulation of insulin release by glucose-dependent insulinotropic polypeptide (GIP). Effect of a specific glucose-dependent insulinotropic polypeptide receptor antagonist in the rat.

Tseng, C., Kieffer, T. J., Jarboe, L. A., Usdin, T. B., & Wolfe, M. M. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119060 · Cited by 149 · see citing works

Erythromycin Antagonizes the Deceleration of Gastric Emptying by Glucagon-Like Peptide 1 and Unmasks Its Insulinotropic Effect in Healthy Subjects

Meier, J. J., Kemmeries, G., Holst, J. J., & Nauck, M. A. (2005) · Diabetes · doi:10.2337/diabetes.54.7.2212 · Cited by 146 · see citing works

Glucagon-like peptide-1: a major regulator of pancreatic beta-cell function

Perfetti, R., & Merkel, P. A. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1430717 · Cited by 143 · see citing works

Targeting the glucagon receptor family for diabetes and obesity therapy

Cho, Y. M., Merchant, C. E., & Kieffer, T. J. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.05.009 · Cited by 142 · see citing works

Carbohydrate Metabolism and Its Disorders

Kaneko, J. J. (1980) · Elsevier eBooks · doi:10.1016/b978-0-12-396350-5.50006-1 · Cited by 142 · see citing works

The Enteroinsular Axis and the Recovery from Type 2 Diabetes after Bariatric Surgery

Patriti, A., Facchiano, E., Sanna, A., Gullà, N., & Donini, A. (2004) · Obesity Surgery · doi:10.1381/0960892041590818 · Cited by 139 · see citing works

Changes in Insulin Resistance Following Bariatric Surgery and the Adipoinsular Axis: Role of the Adipocytokines, Leptin, Adiponectin and Resistin

Ballantyne, G. H., Gumbs, A. A., & Modlin, I. M. (2005) · Obesity Surgery · doi:10.1381/0960892053923789 · Cited by 131 · see citing works

Lipids and Lipid Metabolism

Masoro, E. J. (1977) · Annual Review of Physiology · doi:10.1146/annurev.ph.39.030177.001505 · Cited by 130 · see citing works

Glucose-dependent insulinotropic polypeptide receptor null mice exhibit compensatory changes in the enteroinsular axis

Pamir, N., Lynn, F. C., Buchan, A. M. J., Ehses, J., Hinke, S. A., Pospisilik, J. A., Miyawaki, K., Yamada, Y., Seino, Y., McIntosh, C. H. S., et al. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00270.2002 · Cited by 126 · see citing works

Preservation of incretin activity after removal of gastric inhibitory polypeptide (GIP) from rat gut extracts by immunoadsorption

Ebert, R., Unger, H., & Creutzfeldt, W. (1983) · Diabetologia · doi:10.1007/bf00257346 · Cited by 120 · see citing works

Pathophysiology of Diabetes Mellitus

Sherwin, R., & Felig, P. (1978) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)31766-7 · Cited by 120 · see citing works

Incretin hormone mimetics and analogues in diabetes therapeutics

Green, B. D., & Flatt, P. R. (2007) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2007.09.003 · Cited by 113 · see citing works

Carbohydrate Homeostasis

Levine, R., & Haft, D. E. (1970) · New England Journal of Medicine · doi:10.1056/nejm197007232830405 · Cited by 114 · see citing works

Structurally Modified Analogues of Glucagon-Like Peptide-1 (GLP-1) and Glucose-Dependent Insulinotropic Polypeptide (GIP) As Future Antidiabetic Agents

Green, B., Gault, V., O'Harte, F., & Flatt, P. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043382774 · Cited by 111 · see citing works

Neural regulation of the endocrine pancreas

Brunicardi, F., Shavelle, D., & Andersen, D. (1995) · International Journal of Pancreatology · doi:10.1007/bf02784941 · Cited by 106 · see citing works

Therapeutic potential for GIP receptor agonists and antagonists

Irwin, N., & Flatt, P. R. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.03.001 · Cited by 105 · see citing works

Metformin Effects on Dipeptidylpeptidase IV Degradation of Glucagon-like Peptide-1

Hinke, S. A., Kühn‐Wache, K., Hoffmann, T., Pederson, R. A., McIntosh, C. H. S., & Demuth, H. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6607 · Cited by 105 · see citing works

Effects of oral fructose and glucose on plasma GLP-1 and appetite in normal subjects

Kong, M., Chapman, I. M., Goble, E., Wishart, J. M., Wittert, G., Morris, H. A., & Horowitz, M. (1999) · Peptides · doi:10.1016/s0196-9781(99)00006-6 · Cited by 104 · see citing works

The [pre-] history of the incretin concept

Creutzfeldt, W. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2004.08.004 · Cited by 104 · see citing works

Improved glucose tolerance in rats treated with the dipeptidyl peptidase IV (CD26) inhibitor Ile-thiazolidide

Pauly, R. P., Demuth, H., Rosche, F., Schmidt, J., White, H. A., Lynn, F. C., McIntosh, C. H. S., & Pederson, R. A. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90090-2 · Cited by 103 · see citing works

The Origin and Understanding of the Incretin Concept

Rehfeld, J. F. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00387 · Cited by 102 · see citing works

Glucagon-like peptide-1 evokes action potentials and increases cytosolic Ca2+ in rat nodose ganglion neurons

Kakei, M., Yada, T., Nakagawa, A., & Nakabayashi, H. (2002) · Autonomic Neuroscience · doi:10.1016/s1566-0702(02)00182-0 · Cited by 102 · see citing works

Gastric Inhibitory Polypeptide Release after Oral Glucose: Relationship to Glucose Intolerance, Diabetes Mellitus, and Obesity

Salera, M., Giacomoni, P., Pironi, L., Cornia, G. L., Capelli, M., Marini, A. M., Benfenati, F., Miglioli, M., & Barbara, L. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-55-2-329 · Cited by 101 · see citing works

Glucose-dependent insulinotropic polypeptide (GIP)

Müller, T. D., Adriaenssens, A. E., Ahrén, B., Blüher, M., Birkenfeld, A. L., Campbell, J. E., Coghlan, M. P., D’Alessio, D. D., Deacon, C. F., DelPrato, S., et al. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102118 · Cited by 99 · see citing works

K-cells and Glucose-Dependent Insulinotropic Polypeptide in Health and Disease

Cho, Y. M., & Kieffer, T. J. (2010) · Vitamins and hormones · doi:10.1016/b978-0-12-381517-0.00004-7 · Cited by 93 · see citing works

Oral glucose is the prime elicitor of preabsorptive insulin secretion

Grill, H. J., Berridge, K. C., & Ganster, D. J. (1984) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1984.246.1.r88 · Cited by 92 · see citing works

Gastrointestinal peptides and insulin secretion

Ebert, R., & Creutzfeldt, W. (1987) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610030101 · Cited by 90 · see citing works

Glucagon‐like peptide‐1(7–36) amide is a new incretin/enterogastrone candidate

Göke, R., Fehmann, H. C., & Göke, B. (1991) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1991.tb01802.x · Cited by 90 · see citing works

Dipeptidyl peptidase IV (DPP IV) and related molecules in type 2 diabetes

Flatt, P. R. (2008) · Frontiers in bioscience · doi:10.2741/2956 · Cited by 85 · see citing works

Glucose-Dependent Insulinotropic Polypeptide Confers Early Phase Insulin Release to Oral Glucose in Rats: Demonstration by a Receptor Antagonist1

Lewis, J. T., Dayanandan, B., Habener, J. F., & Kieffer, T. J. (2000) · Endocrinology · doi:10.1210/endo.141.10.7750 · Cited by 85 · see citing works

The milieu interieur and the islets of Langerhans

Unger, R. H. (1981) · Diabetologia · doi:10.1007/bf00253809 · Cited by 84 · see citing works

Physiology and Emerging Biochemistry of the Glucagon-Like Peptide-1 Receptor

Willard, F. S., & Sloop, K. W. (2012) · Experimental Diabetes Research · doi:10.1155/2012/470851 · Cited by 81 · see citing works

Glucagon-Like Peptide-1, But Not Glucose-Dependent Insulinotropic Peptide, Regulates Fasting Glycemia and Nonenteral Glucose Clearance in Mice

Baggio, L. L., Kieffer, T. J., & Drucker, D. J. (2000) · Endocrinology · doi:10.1210/endo.141.10.7720 · Cited by 79 · see citing works

Metabolic Regulation of Plasma Insulin Levels in Cattle

McAtee, J. W., & Trenkle, A. H. (1971) · Journal of Animal Science · doi:10.2527/jas1971.332438x · Cited by 79 · see citing works

Immunocytochemical evidence for a paracrine interaction between GIP and GLP-1-producing cells in canine small intestine

Damholt, A. B., Kofod, H., & Buchan, A. M. J. (1999) · Cell and Tissue Research · doi:10.1007/s004419900093 · Cited by 78 · see citing works

Secretion of incretin hormones and the insulinotropic effect of gastric inhibitory polypeptide in women with a history of gestational diabetes

Meier, J. J., Gallwitz, B., Askenas, M., Vollmer, K., Deacon, C. F., Holst, J. J., Schmidt, W. E., & Nauck, M. A. (2005) · Diabetologia · doi:10.1007/s00125-005-1863-7 · Cited by 77 · see citing works

Prolonged Successful Therapy for Hyperinsulinaemic Hypoglycaemia after Gastric Bypass: The Pathophysiological Role of GLP1 and Its Response to a Somatostatin Analogue

Myint, K. S., Greenfield, J. R., Farooqi, I. S., Henning, E., Holst, J. J., & Finer, N. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-1065 · Cited by 77 · see citing works

Gastric inhibitory polypeptide modulates adiposity and fat oxidation under diminished insulin action

Zhou, H., Yamada, Y., Tsukiyama, K., Miyawaki, K., Hosokawa, M., Nagashima, K., Toyoda, K., Naitoh, R., Mizunoya, W., Fushiki, T., et al. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.164 · Cited by 76 · see citing works

Incretin hormones - an update

Holst, J. J., & Ørskov, C. (2001) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/clb.61.234.75.85 · Cited by 76 · see citing works

Glucagon, gastrin, and carcinoid tumors of the duodenum, pancreas, and stomach: Polypeptide “apudomas” of the foregut

Friesen, S. R., Hermreck, A. S., & Mantz, F. A. (1974) · The American Journal of Surgery · doi:10.1016/0002-9610(74)90017-8 · Cited by 71 · see citing works

The Insulinotropic Effect of Endogenous Gastric Inhibitory Polypeptide in Normal Subjects

Crockett, S. E., Cataland, S., Falko, J. M., & Mazzaferri, E. L. (1976) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-42-6-1098 · Cited by 70 · see citing works

Metabolic Mechanisms in Obesity and Type 2 Diabetes: Insights from Bariatric/Metabolic Surgery

Cătoi, A. F., Pârvu, A. E., Mureșan, A., & Busetto, L. (2015) · Obesity Facts · doi:10.1159/000441259 · Cited by 68 · see citing works

Glucagon-like peptide-1(7–37)/(7–36)amide is a new incretin

Fehmann, H. C., Göke, R., & Göke, B. (1992) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(92)90118-p · Cited by 66 · see citing works

Intraportal GLP-1 stimulates insulin secretion predominantly through the hepatoportal-pancreatic vagal reflex pathways

Nishizawa, M., Nakabayashi, H., Uehara, K., Nakagawa, A., Uchida, K., & Koya, D. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00565.2012 · Cited by 64 · see citing works

An extract of Gymnema sylvestre leaves and purified gymnemic acid inhibits glucose-stimulated gastric inhibitory peptide secretion in rats.

Fushiki, T., Kojima, A., Imoto, T., Inoue, K., & Sugimoto, E. (1992) · Journal of NutriLife · doi:10.1093/jn/122.12.2367 · Cited by 73 · see citing works

Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin

Svendsen, P. F., Nilas, L., Madsbad, S., & Holst, J. J. (2009) · Metabolism · doi:10.1016/j.metabol.2008.11.009 · Cited by 64 · see citing works

Immune recognition and response to the intestinal microbiome in type 1 diabetes

Paun, A., Yau, C., & Danska, J. S. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.02.004 · Cited by 62 · see citing works

The gastrointestinal stimulus to insulin release

Kraegen, E. W., Chisholm, D. J., Young, J. D., & Lazarus, L. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106262 · Cited by 61 · see citing works

Suppressive effect of secretin upon pancreatic alpha cell function

Santeusanio, F., Faloona, G. R., & Unger, R. H. (1972) · Journal of Clinical Investigation · doi:10.1172/jci106975 · Cited by 60 · see citing works

Radioimmunoassay of Plasma Hormones: Review of Plasma Insulin in Ruminants

Trenkle, A. H. (1972) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(72)85648-0 · Cited by 59 · see citing works

Physiological Role of Cholecystokinin in Meal-Induced Insulin Secretion in Conscious Rats: Studies With L 364718, A Specific Inhibitor of CCK-Receptor Binding

Rossetti, L., Shulman, G. I., & Zawalich, W. S. (1987) · Diabetes · doi:10.2337/diab.36.10.1212 · Cited by 57 · see citing works

Elevated Plasma Glucose-Dependent Insulinotropic Polypeptide Associates With Hyperinsulinemia in Impaired Glucose Tolerance

Theodorakis, M. J., Carlson, O. D., Muller, D. C., & Egan, J. M. (2004) · Diabetes Care · doi:10.2337/diacare.27.7.1692 · Cited by 55 · see citing works

Metabolic control in diabetic pregnancy

Persson, B., & Lunell, N. (1975) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(75)90580-3 · Cited by 55 · see citing works

The role of the Wnt signaling pathway in incretin hormone production and function

Chiang, Y., Ip, W., & Jin, T. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00273 · Cited by 56 · see citing works

Applications of dipeptidyl peptidase IV inhibitors in diabetes mellitus

McIntosh, C. H. S., Demuth, H., Kim, S.-J., Pospisilik, J. A., & Pederson, R. A. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.12.013 · Cited by 54 · see citing works

Glucagon-like Peptide-1 (GLP-1) and the Control of Glucose Metabolism in Mammals and Teleost Fish1

Mojsov, S. (2000) · American Zoologist · doi:10.1668/0003-1569(2000)040[0246:glpgat]2.0.co;2 · Cited by 51 · see citing works

Gastric Inhibitory Polypeptide (GIP) Release and Incretin Effect after Oral Glucose in Obesity and after Jejunoileal Bypass

Lauritsen, K. B., Christensen, K. C., & Stokholm, K. H. (1980) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528009181506 · Cited by 51 · see citing works

Stimulation of adenylate cyclase from isolated hepatocytes and Kupffer cells.

Wincek, T. J., Hupka, A. L., & Sweat, F. W. (1975) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)40753-9 · Cited by 51 · see citing works

Reactive hypoglycemia

Hofeldt, F. D. (1975) · Metabolism · doi:10.1016/0026-0495(75)90156-0 · Cited by 50 · see citing works

Effects of gut hormone on insulin and glucagon secretion

Ohneda, A., Ketterer, H., Eisentraut, A. M., & Unger, R. H. (1968) · Acta Diabetologica · doi:10.1007/bf01545355 · Cited by 7 · see citing works

Gastrointestinal hormone and amino acid induced insulin release from isolated pancreatic islets of Langerhans

Curtis, J. D. (1969) · eScholarship@McGill (McGill) · doi:10.82308/33916

The Effects of Secretin, Pancreozymin, and Gastrin on Insulin and Glucagon Secretion in Anesthetized Dogs *

Unger, R. H., Ketterer, H., Dupré, J., & Eisentraut, A. M. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105565 · Cited by 337 · see citing works

The Enteroinsular Axis Revisited

Ensinck, J. W., & D’Alessio, D. A. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205143262009 · Cited by 24 · see citing works

The influence of glucose on gastrin and insulin release in the enteroinsular axis.

Friesen, BOLINGER, R. E., & Jl, K. (1974) · PubMed · Cited by 1 · see citing works